Abstract
Molecular topology has been applied to the search of QSAR models able to identify the anti-allergic activity of a wide group of heterogeneous compounds. Through the linear discriminant analysis and artificial neural networks, correct classification percentages above 85% for both the training set and the test set have been obtained. After carrying out a virtual screening with a natural product library, about thirty compounds with theoretical anti-allergic activity have been selected. Among them, hesperidin, naringin, salinomycin, sorbitol, curcumol, myricitrin, diosmin and kinetin stand out. Some of these compounds have already been referenced as having anti-allergic activity.
Keywords: Anti-allergic drugs, artificial neural networks, linear discriminant analysis, molecular topology, natural products, pattern recognition, QSAR.
Combinatorial Chemistry & High Throughput Screening
Title:Modeling Anti-Allergic Natural Compounds by Molecular Topology
Volume: 16 Issue: 8
Author(s): Ramon Garcia-Domenech, Riccardo Zanni, Maria Galvez-Llompart and J. Vicente de Julian-Ortiz
Affiliation:
Keywords: Anti-allergic drugs, artificial neural networks, linear discriminant analysis, molecular topology, natural products, pattern recognition, QSAR.
Abstract: Molecular topology has been applied to the search of QSAR models able to identify the anti-allergic activity of a wide group of heterogeneous compounds. Through the linear discriminant analysis and artificial neural networks, correct classification percentages above 85% for both the training set and the test set have been obtained. After carrying out a virtual screening with a natural product library, about thirty compounds with theoretical anti-allergic activity have been selected. Among them, hesperidin, naringin, salinomycin, sorbitol, curcumol, myricitrin, diosmin and kinetin stand out. Some of these compounds have already been referenced as having anti-allergic activity.
Export Options
About this article
Cite this article as:
Garcia-Domenech Ramon, Zanni Riccardo, Galvez-Llompart Maria and Julian-Ortiz Vicente de J., Modeling Anti-Allergic Natural Compounds by Molecular Topology, Combinatorial Chemistry & High Throughput Screening 2013; 16 (8) . https://dx.doi.org/10.2174/1386207311316080005
DOI https://dx.doi.org/10.2174/1386207311316080005 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dipeptidyl Peptidase-4 Inhibitor Induced Angioedema – An Overlooked Adverse Drug Reaction?
Current Diabetes Reviews Nummular Eczema: An Updated Review
Recent Patents on Inflammation & Allergy Drug Discovery The Emerging Role of Bradykinin in the Pathogenesis of Osteoarthritis and its Possible Clinical Implications
Current Rheumatology Reviews The Phage Display Technique: Advantages and Recent Patents
Recent Patents on DNA & Gene Sequences Target Product Selection - Where Can Molecular Pharming Make the Difference?
Current Pharmaceutical Design Design, Development and Optimization of Ramipril Solid Lipid Nanoparticles Using Solvent Emulsification and Evaporation Method
Nanoscience & Nanotechnology-Asia Adamantane – A Lead Structure for Drugs in Clinical Practice
Current Medicinal Chemistry A Systematic Approach to Assess the Burden of Drug Interactions in Adult Kidney Transplant Patients
Current Drug Safety Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain
Current Drug Targets G-protein Dependent Platelet Signaling - Perspectives for Therapy
Current Drug Targets Irbesartan and Hydrochlorothiazide Association in the Treatment of Hypertension
Current Vascular Pharmacology Drug Treatment of Metabolic Syndrome
Current Clinical Pharmacology Challenges in the Management of Severe Asthma: Role of Current and Future Therapies
Current Pharmaceutical Design Safety of Systemic Biologic Agents in the Treatment of Non-malignant Skin Disorders
Current Drug Safety Evaluation of Allergic Reactions Following Intravenous Infusion of Polyvalent Antivenom in Snakebite Patients
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Acute and Long-Term Effects of Cannabis Use: A Review
Current Pharmaceutical Design Targeting Interleukin (IL) 5 for Asthma and Hypereosinophilic Diseases
Recent Patents on Inflammation & Allergy Drug Discovery ADR in Journals: Are They Translated into Regulatory Frameworks?
Current Drug Safety Cow’s Milk Allergy in Children, from Avoidance to Tolerance
Endocrine, Metabolic & Immune Disorders - Drug Targets Provocation Tests in Diagnosing Drug Hypersensitivity
Current Pharmaceutical Design